ACA
Avoro Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,674,835
| Closed | -$171M | – | 33 |
|
|
2025
Q1 | $171M | Buy |
2,674,835
+119,280
| +5% | +$7.61M | 2.66% | 12 |
|
|
2024
Q4 | $311M | Hold |
2,555,555
| – | – | 4.4% | 7 |
|
|
2024
Q3 | $319M | Sell |
2,555,555
-444,445
| -15% | -$55.5M | 4.65% | 7 |
|
|
2024
Q2 | $474M | Sell |
3,000,000
-1,344,444
| -31% | -$212M | 6.31% | 5 |
|
|
2024
Q1 | $562M | Hold |
4,344,444
| – | – | 6.56% | 4 |
|
|
2023
Q4 | $419M | Buy |
4,344,444
+319,444
| +8% | +$30.8M | 5.79% | 6 |
|
|
2023
Q3 | $488M | Sell |
4,025,000
-602,888
| -13% | -$73.1M | 7.61% | 4 |
|
|
2023
Q2 | $530M | Buy |
4,627,888
+977,888
| +27% | +$112M | 7.19% | 4 |
|
|
2023
Q1 | $503M | Buy |
3,650,000
+475,000
| +15% | +$65.5M | 7.46% | 4 |
|
|
2022
Q4 | $411M | Hold |
3,175,000
| – | – | 6.15% | 6 |
|
|
2022
Q3 | $351M | Sell |
3,175,000
-215,000
| -6% | -$23.8M | 6.48% | 5 |
|
|
2022
Q2 | $254M | Buy |
3,390,000
+255,000
| +8% | +$19.1M | 5.02% | 9 |
|
|
2022
Q1 | $245M | Buy |
3,135,000
+10,000
| +0.3% | +$781K | 4.47% | 8 |
|
|
2021
Q4 | $281M | Buy |
3,125,000
+625,000
| +25% | +$56.3M | 4.79% | 6 |
|
|
2021
Q3 | $231M | Buy |
2,500,000
+100,000
| +4% | +$9.25M | 3.63% | 7 |
|
|
2021
Q2 | $187M | Buy |
2,400,000
+250,000
| +12% | +$19.4M | 3.25% | 9 |
|
|
2021
Q1 | $160M | Buy |
2,150,000
+400,000
| +23% | +$29.8M | 2.77% | 11 |
|
|
2020
Q4 | $298M | Buy |
1,750,000
+75,000
| +4% | +$12.8M | 5.14% | 7 |
|
|
2020
Q3 | $235M | Hold |
1,675,000
| – | – | 3.34% | 8 |
|
|
2020
Q2 | $269M | Buy |
1,675,000
+90,000
| +6% | +$14.4M | 5.31% | 5 |
|
|
2020
Q1 | $155M | Sell |
1,585,000
-175,000
| -10% | -$17.1M | 5.23% | 6 |
|
|
2019
Q4 | $227M | Buy |
1,760,000
+82,000
| +5% | +$10.6M | 6.67% | 5 |
|
|
2019
Q3 | $126M | Buy |
1,678,000
+278,000
| +20% | +$20.9M | 5.27% | 7 |
|
|
2019
Q2 | $213M | Buy |
1,400,000
+205,000
| +17% | +$31.1M | 7.35% | 5 |
|
|
2019
Q1 | $142M | Sell |
1,195,000
-80,000
| -6% | -$9.54M | 6.16% | 5 |
|
|
2018
Q4 | $139M | Buy |
1,275,000
+331,500
| +35% | +$36.2M | 8.32% | 3 |
|
|
2018
Q3 | $152M | Sell |
943,500
-15,428
| -2% | -$2.49M | 7% | 3 |
|
|
2018
Q2 | $127M | Buy |
+958,928
| New | +$127M | 4.88% | 7 |
|
|
2017
Q1 | – | Sell |
-1,010,300
| Closed | -$27.7M | – | 45 |
|
|
2016
Q4 | $27.7M | Sell |
1,010,300
-359,609
| -26% | -$9.86M | 5.6% | 6 |
|
|
2016
Q3 | $84.1M | Sell |
1,369,909
-42,281
| -3% | -$2.6M | 14.76% | 1 |
|
|
2016
Q2 | $26.9M | Buy |
1,412,190
+257,190
| +22% | +$4.9M | 5.98% | 6 |
|
|
2016
Q1 | $22.5M | Buy |
1,155,000
+651,993
| +130% | +$12.7M | 7.87% | 4 |
|
|
2015
Q4 | $19.4M | Buy |
503,007
+33,982
| +7% | +$1.31M | 6.68% | 5 |
|
|
2015
Q3 | $15.1M | Buy |
+469,025
| New | +$15.1M | 3.92% | 11 |
|